BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31068469)

  • 21. Prospective comparison of (4S)-4-(3-
    Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrosis and cancer: A strained relationship.
    Piersma B; Hayward MK; Weaver VM
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188356. PubMed ID: 32147542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME)
    Nabavizadeh A; Payen T; Iuga AC; Sagalovskiy IR; Desrouilleres D; Saharkhiz N; Palermo CF; Sastra SA; Oberstein PE; Rosario V; Kluger MD; Schrope BA; Chabot JA; Olive KP; Konofagou EE
    Theranostics; 2020; 10(10):4614-4626. PubMed ID: 32292518
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
    Zimmermann C; Distler M; Jentsch C; Blum S; Folprecht G; Zöphel K; Polster H; Troost EGC; Abolmaali N; Weitz J; Baumann M; Saeger HD; Grützmann R
    Strahlenther Onkol; 2021 Jan; 197(1):19-26. PubMed ID: 32638040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nanobody-based nuclear imaging tracer targeting dipeptidyl peptidase 6 to determine the mass of human beta cell grafts in mice.
    Demine S; Garcia Ribeiro R; Thevenet J; Marselli L; Marchetti P; Pattou F; Kerr-Conte J; Devoogdt N; Eizirik DL
    Diabetologia; 2020 Apr; 63(4):825-836. PubMed ID: 31873789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma.
    Jian Z; Cheng T; Zhang Z; Raulefs S; Shi K; Steiger K; Maeritz N; Kleigrewe K; Hofmann T; Benitz S; Bruns P; Lamp D; Jastroch M; Akkan J; Jäger C; Huang P; Nie S; Shen S; Zou X; Ceyhan GO; Michalski CW; Friess H; Kleeff J; Kong B
    Cell Mol Gastroenterol Hepatol; 2018; 6(4):429-449. PubMed ID: 30258965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early Response Assessment in Pancreatic Ductal Adenocarcinoma Through Integrated PET/MRI.
    Wang ZJ; Behr S; Consunji MV; Yeh BM; Ohliger MA; Gao K; Ko AH; Cinar P; Tempero MA; Collisson EA
    AJR Am J Roentgenol; 2018 Nov; 211(5):1010-1019. PubMed ID: 30063366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical Evaluation of
    Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
    Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.
    Ahmad RS; Eubank TD; Lukomski S; Boone BA
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance molecular imaging of extradomain B fibronectin enables detection of pancreatic ductal adenocarcinoma metastasis.
    Qiao PL; Gargesha M; Liu Y; Laney VEA; Hall RC; Vaidya AM; Gilmore H; Gawelek K; Scott BB; Roy D; Wilson DL; Lu ZR
    Magn Reson Imaging; 2022 Feb; 86():37-45. PubMed ID: 34801672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomics model of dual-time 2-[
    Liu Z; Li M; Zuo C; Yang Z; Yang X; Ren S; Peng Y; Sun G; Shen J; Cheng C; Yang X
    Eur Radiol; 2021 Sep; 31(9):6983-6991. PubMed ID: 33677645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Recurrence in Resected Pancreatic Ductal Adenocarcinoma.
    Ariake K; Motoi F; Shimomura H; Mizuma M; Maeda S; Terao C; Tatewaki Y; Ohtsuka H; Fukase K; Masuda K; Hayashi H; Takadate T; Naitoh T; Taki Y; Unno M
    J Gastrointest Surg; 2018 Feb; 22(2):279-287. PubMed ID: 29119533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
    Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
    Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Can We Learn About Pancreatic Adenocarcinoma from Imaging?
    Rosenthal M; Schawkat K; Muftah M; Jajoo K
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):911-928. PubMed ID: 36265990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.
    Mueller AC; Piper M; Goodspeed A; Bhuvane S; Williams JS; Bhatia S; Phan AV; Van Court B; Zolman KL; Peña B; Oweida AJ; Zakem S; Meguid C; Knitz MW; Darragh L; Bickett TE; Gadwa J; Mestroni L; Taylor MRG; Jordan KR; Dempsey P; Lucia MS; McCarter MD; Del Chiaro M; Messersmith WA; Schulick RD; Goodman KA; Gough MJ; Greene CS; Costello JC; Neto AG; Lagares D; Hansen KC; Van Bokhoven A; Karam SD
    Cancer Res; 2021 Jun; 81(12):3255-3269. PubMed ID: 33526513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing local progression after stereotactic body radiation therapy for unresectable pancreatic adenocarcinoma: CT versus PET.
    Toesca DAS; Pollom EL; Poullos PD; Flynt L; Cui Y; Quon A; von Eyben R; Koong AC; Chang DT
    Pract Radiat Oncol; 2017; 7(2):120-125. PubMed ID: 28274396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis.
    Van Impe K; Bethuyne J; Cool S; Impens F; Ruano-Gallego D; De Wever O; Vanloo B; Van Troys M; Lambein K; Boucherie C; Martens E; Zwaenepoel O; Hassanzadeh-Ghassabeh G; Vandekerckhove J; Gevaert K; Fernández LÁ; Sanders NN; Gettemans J
    Breast Cancer Res; 2013 Dec; 15(6):R116. PubMed ID: 24330716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.